Showing results (601-610 of 1,547) with videos related to
Sort By:
Pageof 155
Cancer Reports (Hoboken, N.J.)|May 13, 2026
Decoding the Oncogenic Role of USP22 Through Pan-Cancer Genomic and Epigenetic AnalysisUma Devi A, Prakash Kumar ShuklaCancer Reports (Hoboken, N.J.)|March 12, 2026
Ten-Year Outcome of a Patient With Concurrent Pelvic Myeloid Sarcoma and Underlying Chronic Myeloid Leukaemia in Chronic Phase: A Case Report and Literature ReviewKar Ying Yong, Soo How Lim, Lee Gong Lau, et al.Cancer Reports (Hoboken, N.J.)|February 28, 2026
Successful Management of Suspected Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis in BRAF-Mutant Cholangiocarcinoma Following Treatment With Immune Checkpoint Inhibitors and BRAF/MEK Inhibitors: A Case ReportAkira Shibata, Michihiro Ono, Shutaro Oiwa, et al.Cancer Reports (Hoboken, N.J.)|February 10, 2026
Epidemiology and Prognosis of Patients With Osteosarcoma at Different Primary Sites: A SEER Population-Based StudyJianqun Wang, Linglong Zeng, Xiaoxia Li, et al.Cancer Reports (Hoboken, N.J.)|March 7, 2026
Case Report: Co-Occurrence of Lung Adenocarcinoma and Congenital Dysfibrinogenemia-Diagnostic and Perioperative Management ChallengesHe Zheng, Qingsong Wang, Mingpu Wang, et al.Cancer Reports (Hoboken, N.J.)|March 18, 2026
Identification of BRAF V600E Mutation in Cerebrospinal Fluid Aids in Diagnosing Leptomeningeal Carcinomatosis Arising From Pleomorphic Xanthoastrocytoma: A Case ReportRandy S D'Amico, Patricia Avancena, Alon Kashanian, et al.Cancer Reports (Hoboken, N.J.)|February 20, 2026
Acute Gout Flare After Carboplatin/5-Fluorouracil for Locally Advanced Head and Neck Squamous Cell CarcinomaHenry Zou, Anas Al Janadi, Zeyad SakoCancer Reports (Hoboken, N.J.)|February 22, 2026
The Bioinformatics and Experimental Analysis of CD276 for Prognosis and Immune Infiltrates in Colon AdenocarcinomaRui Chen, Tao Zhang, Jingru Yang, et al.Cancer Reports (Hoboken, N.J.)|February 27, 2026
Postoperative Adjuvant Chemoradiotherapy ± PD-1 Inhibitor for Locally Advanced Head and Neck Squamous Cell CarcinomaZhiqiang Wang, Qingqing He, Donghui Jiang, et al.Cancer Reports (Hoboken, N.J.)|February 2, 2023
Dose reduction of docetaxel avoids the usage of pegfilgrastim in docetaxel plus ramucirumab therapy for recurrent nonsmall cell lung cancerKosuke Hamai, Shinya Miyaka, Shinpei Tada, et al.Pageof 155